AstraZeneca boss Pascal Soriot has called on the government to provide access to its Covid-19 medicine Evusheld, saying it’s a “sad situation” that Britain is one of the few developed nations not to have ordered the drug, designed for those with poor immune systems.
His comments came as the company flagged up declining sales of its Covid vaccine, developed with the University of Oxford. Strong performances by other medicines for cancer, diabetes and other conditions catapulted overall sales 60% higher to $11.4bn (£9bn) in the first three months of the year, despite the pandemic affecting cancer diagnosis rates.
